Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER versus SODIUM ACETATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER versus SODIUM ACETATE.
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER vs SODIUM ACETATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium ion is essential for normal cell function, including muscle contraction, nerve transmission, and blood coagulation. It acts as a positive inotrope by increasing myocardial contractility and also corrects hypocalcemia.
Sodium acetate provides sodium ions and acetate ions. Acetate is metabolized to bicarbonate, which acts as a buffer to correct metabolic acidosis.
IV: 500 mg to 1 g (5-10 mL of 10% solution) administered slowly at a rate not exceeding 0.5-1 mL/min. May be repeated as needed based on serum calcium levels and clinical response.
Intravenous: 50-200 mL of 0.1-0.4 mEq/mL solution per dose; administer at a rate not exceeding 1 mEq/kg/hour; frequency based on serum bicarbonate and acid-base status.
None Documented
None Documented
2-4 hours in patients with normal renal function; prolonged in renal impairment.
2-3 minutes (rapid conversion to bicarbonate in circulation). Clinical context: Exogenous acetate (e.g., in parenteral nutrition) is quickly cleared, limiting duration of alkalinizing effect.
Primarily renal (80-90% as ionized calcium); minor fecal elimination (<10%).
Primarily renal; acetate is rapidly metabolized to bicarbonate via the Krebs cycle, with less than 5% excreted unchanged in urine.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement